Sector News

DuPont considers potential $20B sale of biosciences unit – Bloomberg

August 7, 2019
Chemical Value Chain

DuPont (DD +3.8%) is considering unloading its nutrition and biosciences division, and is working with advisers to evaluate options that could include selling or spinning off the business, Bloomberg reports.

The division, which makes food additives and ingredients, could be worth at least $20B as a stand-alone entity, based on the trading multiples of rivals, according to the report.

Logical partners for such a deal are said to include International Flavors & Fragrances (NYSE:IFF), Kerry Group (OTCPK:KRYAY), Givaudan (OTCPK:GVDBF) and Royal DSM.

By: Carl Surran

Source: Seeking Alpha

Join the discussion!

Your email address will not be published. Required fields are marked *

Related News

January 23, 2021

Bayer AG appoints Sarena Lin as Chief Transformation and Talent Officer

Chemical Value Chain

Lin will become the company’s Chief Transformation and Talent Officer. She will be responsible for Human Resources, Strategy and Business Consulting and drive the accelerated transformation of Bayer.

January 23, 2021

Johnson Matthey’s battery plant in Poland to be powered by renewable electricity 

Chemical Value Chain

Johnson Matthey plc (JM; London) has confirmed that its battery cathode materials plant in Konin, Poland, will be powered solely by electricity from renewable sources from day one of production.

January 23, 2021

Oxford given £100m for antibiotic resistance research

Chemical Value Chain

Britain’s Oxford University has received a donation of £100 million (112 million euros, $136 million) to research growing resistance to antibiotics, the university announced on Tuesday. The sum, from British chemicals multinational Ineos, is one of the largest donations given to Oxford University in its long history.

Send this to a friend